Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2565 studies found for:    Schizophrenia
Show Display Options
Rank Status Study
1 Recruiting Trial of DMXB-A in Schizophrenia
Condition: Schizophrenia
Interventions: Drug: 3-2,4 dimethoxybenzylidene 75 or 150 mg bid;   Drug: Placebo
2 Terminated A Study on Etiological Factors of Schizophrenia
Condition: Schizophrenia
Intervention:
3 Not yet recruiting The Optimal Treatment for Treatment-resistant Schizophrenia
Condition: Schizophrenia
Interventions: Drug: Risperidone with Clozapine;   Drug: Aripiprazole with Clozapine;   Drug: sodium valproate with Clozapine;   Device: modified electroconvulsive therapy(MECT) with Clozapine;   Device: Magnetic seizure therapy(MST) with Clozapine
4 Completed Safety and Efficacy of Seroquel in First Episode Schizophrenia
Condition: Schizophrenia
Intervention: Drug: Seroquel and Risperidone
5 Unknown  Minocycline Augmentation in Schizophrenia
Condition: Schizophrenia
Interventions: Drug: Minocycline;   Drug: Placebo
6 Completed
Has Results
Genetic Research in Schizophrenia Using DNA Markers and Clinical Phenotypes
Condition: Schizophrenia
Intervention: Other: Diagnostic
7 Completed Ziprasidone in Early Onset Schizophrenia Spectrum Disorders
Condition: Schizophrenia
Intervention: Drug: Ziprasidone
8 Terminated Study Evaluating Bifeprunox in Patients With Schizophrenia.
Condition: Schizophrenia
Intervention: Drug: Bifeprunox
9 Completed Fast Titration in the Treatment of Schizophrenia, Taiwan
Condition: Schizophrenia
Intervention: Drug: Quetiapine fumarate
10 Completed
Has Results
Phase IIA Study in Patients With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: AZD2624;   Drug: Olanzapine;   Drug: Placebo
11 Completed Study Evaluating RGH-188 in the Treatment of Patients With Schizophrenia
Condition: Schizophrenia
Intervention: Drug: RGH-188
12 Not yet recruiting Evaluation Study of New Compounds With Potential Use in Schizophrenia
Condition: Schizophrenia
Interventions: Drug: URB597;   Drug: intranasal Insulin;   Drug: Cannabidiol CR
13 Completed High-Dose Oral Ziprasidone Versus Conventional Dosing in Schizophrenia Patients With Residual Symptoms
Condition: Schizophrenia
Intervention: Drug: Geodon
14 Not yet recruiting An Extension Study of Safety and Tolerability of SEP-363856 in Adult Subjects With Schizophrenia
Condition: Schizophrenia
Intervention: Drug: SEP-363856
15 Completed Study on Metabolic Parameters of Sertindole in Patients With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: Sertindole;   Drug: Olanzapine
16 Completed Exploratory Cognition Study of Sertindole in Patients With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: Sertindole;   Drug: Olanzapine
17 Completed Study Evaluating SCA-136 in Subjects With Acute Exacerbations of Schizophrenia
Condition: Schizophrenia
Interventions: Drug: SCA-136 (200 mg);   Drug: SCA-136 (400 mg);   Drug: olanzapine (15 mg);   Drug: placebo
18 Active, not recruiting An Open-Label, Multicenter, Rollover, Long-term Study of Aripiprazole Intramuscular Depot in Patients With Schizophrenia
Condition: Schizophrenia
Intervention: Drug: Aripiprazole
19 Completed
Has Results
Aripiprazole in Adolescents With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: Aripiprazole tablet, 10 mg;   Drug: Aripiprazole tablet, 30 mg;   Drug: Placebo tablet
20 Recruiting Insight in Persons Presenting Schizophrenia or Related Troubles During Hospitalization in Psychiatry
Condition: Schizophrenia
Intervention: Other: insight variation measure

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.